1. Stem Cells and Regenerative Medicine

Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype

  1. Antonion Korcari
  2. Anne EC Nichols
  3. Mark R Buckley
  4. Alayna E Loiselle  Is a corresponding author
  1. Center for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, United States
  2. Department of Biomedical Engineering, University of Rochester, United States
https://doi.org/10.7554/eLife.84194
Share this article
Cite this article
  1. Antonion Korcari
  2. Anne EC Nichols
  3. Mark R Buckley
  4. Alayna E Loiselle
(2023)
Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype
eLife 12:e84194.
https://doi.org/10.7554/eLife.84194
  2. Download BibTeX
  3. Download .RIS

Abstract

Aged tendons have disrupted homeostasis, increased injury risk, and impaired healing capacity. Understanding mechanisms of homeostatic disruption is crucial for developing therapeutics to retain tendon health through the lifespan. Here, we developed a novel model of accelerated tendon extracellular matrix (ECM) aging via depletion of Scleraxis-lineage cells in young mice (Scx-DTR). Scx-DTR recapitulates many aspects of tendon aging including comparable declines in cellularity, alterations in ECM structure, organization, and composition. Single-cell RNA sequencing demonstrated a conserved decline in tenocytes associated with ECM biosynthesis in aged and Scx-DTR tendons, identifying the requirement for Scleraxis-lineage cells during homeostasis. However, the remaining cells in aged and Scx-DTR tendons demonstrate functional divergence. Aged tenocytes become pro-inflammatory and lose proteostasis. In contrast, tenocytes from Scx-DTR tendons demonstrate enhanced remodeling capacity. Collectively, this study defines Scx-DTR as a novel model of accelerated tendon ECM aging and identifies novel biological intervention points to maintain tendon function through the lifespan.

Editor's evaluation

This fundamental work advances our understanding of the cellular and molecular changes of the aged tendon. The evidence supporting the conclusion is convincing, using a DTR-based ScxLin cell depletion model along with state-of-art proteomic and scRNA-seq analyses. This paper is of potential interest to scientists and physicians who study the mechanisms of the tendon aging process.

https://doi.org/10.7554/eLife.84194.sa0

Introduction

Tendons are dense connective tissues that transmit muscle-generated forces to bone to enable skeletal movement and joint stability. Recent studies from our group and others have demonstrated the presence of multiple tendon resident cell populations, with Scleraxis-lineage (ScxLin) cells being the predominant population during adult mouse homeostasis (Best et al., 2021; De Micheli et al., 2020; Best and Loiselle, 2019; Kendal et al., 2020). Scleraxis, a basic helix-loop-helix transcription factor, is the most well-characterized tendon marker (Schweitzer et al., 2001; Murchison et al., 2007; Pryce et al., 2009) and is required for normal tendon development (Schweitzer et al., 2001; Murchison et al., 2007). During adulthood, tendon homeostasis is maintained via ongoing turnover of extracellular matrix (ECM) proteins (Samiric et al., 2004a; Samiric et al., 2004b; Choi et al., 2020; Heinemeier et al., 2016; Rees et al., 2009; Korcari et al., 2021b; Neidlin et al., 2018). Homeostatic disruptions can lead to the development of tendon pathologies such as tendinopathy, which are characterized by significant pain and permanent decline in tissue performance (Millar et al., 2021). While repetitive loading in sports or occupational contexts disrupt homeostasis, natural aging is also associated with impaired tendon homeostasis (Pardes et al., 2017; Connizzo et al., 2013; Peffers et al., 2014; Gehwolf et al., 2016; Wang et al., 2021; Kostrominova and Brooks, 2013; Marqueti et al., 2018; Korcari et al., 2021a). Tendinopathy prevalence increases substantially with age (Riel et al., 2019), making aging a key risk factor for loss of tendon health. Despite this increased risk, the factors responsible for inducing age-related tendinopathy are not well defined.

We have previously shown that depletion of ScxLin cells results in a relatively rapid loss of ECM structural and organizational integrity of the flexor digitorum longus (FDL) tendon (Best et al., 2021), suggesting that ScxLin cells are required to maintain tendon homeostasis. However, the specific mechanisms by which ScxLin cells maintain tendon homeostasis have not been identified. Moreover, while the initial ECM organizational changes that occur with ScxLin cell depletion mimic those that occur during natural aging (Connizzo et al., 2013; Gehwolf et al., 2016; Dunkman et al., 2013; Ippolito et al., 1980; Connizzo et al., 2016), it is unknown whether sustained ScxLin cell depletion in young mice may induce an aged tendon phenotype.

In the present study, our primary objective was to identify the underlying changes in the cellular and molecular environment that result from ScxLin cell depletion in young adult tendons and determine how these structural and compositional shifts compare to those observed during natural aging. Here, we define the mechanisms that are conserved between ScxLin depletion and natural aging to establish the key drivers that underpin the initiation of tendon degeneration and identify novel intervention points to maintain tendon health through the lifespan. Conversely, by defining the divergent molecular programming shifts in the tendon cells that remain during natural aging and inducible depletion of ScxLin tenocytes in young animals, we have identified cell populations and processes that may dictate differences in tendon healing capacity.

Results

Scleraxis-lineage cell depletion in young adults disrupts tendon homeostasis and mimics the cell density and ECM structural alterations of tendon aging

To determine the long-term depletion efficiency of this Scx-DTR (DTR) model, we quantified cell density in DTR mice at 3-, 6-, and 9 months (3, 6, 9 M) post-depletion, and compared to age-matched DT-treated wildtype (WT) littermates (Figure 1A). At 3 M and 6 M post-depletion, there was a respective 57.44% (p<0.0001) and 56.21% (p<0.0001) reduction in total tendon cell density in DTR tendons relative to the WT littermates (Figure 1B and C). By 9 M post-depletion (12 M of age), there was an age-related decrease in tendon cell density in WT such that no significant differences in cell density were observed between DTR and WT (p>0.05) (Figure 1B and C).

Figure 1
Download asset Open asset
Depletion of Scleraxis-lineage cell during long-term homeostasis significantly disrupts tendon structure and mechanical properties.

(A) 3 M old Scx-Cre+; Rosa- DTRF/+ (DTR) and Scx-Cre-; Rosa-DTRF/+ (WT) mice received five hind paw injections of DT and were harvested at 3, 6, and 9 M post-depletion. (B) Quantification of total tendon cell (DAPI) density from injected WT and DTR hind paws at 3-, 6-, and 9 months post-depletion (6, 9, and 12 months old of age, respectively) within the tendon. (C) Representative sections from (B). (D) Quantification of total tendon cell (DAPI) density from C57BL/6 J hind paws at 10, 13, and 31 months old within the tendon. (E) Representative sections from (D). (F) Quantification of collagen fibril dispersion in WT and DTR samples at 3-, 6-, and 9 months post-depletion (6, 9, and 12 months old, respectively) and (G) representative collagen fibril morphology captured via SHG. (H) Quantification of collagen fibril dispersion from C57BL/6 J hind paws at 10, 13, and 31 months old and (I) representative collagen fibril morphology via SHG. N=3–5 per genotype. Error bars indicate mean ± standard deviation.

Based on this decline in cellularity from 9 to 12 M in WT, we further tracked changes in tendon cell density from 10 to 31 months of age in C57BL/6 J mice (Figure 1D). Consistent with the progressive decline in cellularity in WT tendons, cellularity was further decreased at 10 M in C57Bl/6 J tendons, with a 31.62% (p<0.0001) decline in cell density compared to 6 M old WT, and a 32.06% decrease (p<0.0001) compared to 9 M old WT tendons (Figure 1D and E). At 13 and 31 M, C57Bl/6 J FDL tendons showed a 43.19% (p<0.001) and a 44.42% (p<0.001) decrease in total cell density compared to 10 M old C57Bl/6 J FDL tendons, respectively (Figure 1D and E). Intriguingly, 6 M old DTR tendons (3 M post-depletion) exhibited a cell density almost identical to 13 M and 31 M old C57Bl/6 J tendons (p>0.05) (Figure 1D and E), suggesting that with Scleraxis-lineage depletion, young tendons exhibit the same cell density as old (12 M) and geriatric (31 M) tendons (Figure 1D and E).

We then investigated the impact of sustained Scleraxis-lineage cell loss on long-term maintenance of collagen ECM organization. Quantification of collagen dispersion via SHG imaging demonstrated significant increases in dispersion (loss of organization) at 3 M (39.82%, p<0.05), 6 M (41.04%, p<0.01), and 9 M (24.53%, p<0.05) post-DT, relative to WT littermates (Figure 1F and G), indicative of impairments in tissue structure and organization.

We then determined how the structure and organization of the tendon shifts with natural aging, and whether there may be conserved structural changes with both Scleraxis-lineage depletion and aging. Geriatric 31 M old C57Bl/6 J tendons exhibited a significant increase in collagen fibril dispersion compared to 10 M (79.3%; p<0.0001) and 13 M (81.47%, p<0.0001) C57Bl/6 J tendons (Figure 1H1), suggesting aging-induced impairments in tendon structure and organization. No differences in dispersion were observed in 3 M post-DT (6 M old) WT tendons compared to 10 M C57BL/6 J (p>0.05), and 13 M C57BL/6 J (p>0.05) (Figure 1H1). In contrast, 3 M post-DT (6 M old) DTR tendons showed a 45.8% (p<0.01) and a 47.63% (p<0.01) increase in collagen dispersion compared to 10 M and 13 M C57BL/6 J tendons, respectively (Figure 1H1), suggesting that young DTR tendons recapitulate several aspects of age-related deficits in tissue organization. However, geriatric 31 M old C57BL/6 J tendons still had a significantly higher collagen fibril dispersion (+23.02%, p<0.05) compared to 3 M post-DT (6 M old) DTR tendons (Figure 1H1), potentially suggesting further degeneration during advanced aging.

Scleraxis-lineage cells maintain tendon homeostasis by regulating the synthesis of high turnover rate ECM proteins

We next sought to identify the specific biological mechanisms that accompany, and potentially underpin these structural changes by characterizing the proteome of DTR and WT tendons at 3 M post-depletion (6 M old), as well as the proteome of old vs young WT tendons (12 M and 6 M old). At 3 M post-depletion, 30 proteins were significantly different between the DTR and WT groups (Figure 2A). ECM proteins were the most decreased category in DTR tendons, accounting for 26.7% of the total proteins. (Figure 2B). In addition, cytoskeletal proteins, transporters, and scaffold/adaptor proteins were decreased in DTR, though these decreases in inter- and intracellular proteins are likely due to a ~60% reduction in cellularity of the DTR samples. Functional enrichment analysis of all the downregulated proteins demonstrated that ECM-related molecular functions and cellular components were significantly impaired with depletion (Figure 2C). Eleven ECM proteins were decreased in DTR tendons (Figure 2D), and they were classified as proteoglycans (PG) (36.4%), glycoproteins (GP) (36.4%), ECM regulators (18.2%), and ECM-affiliated proteins (9.1%) (Figure 2E). Strikingly, 72.8% of these ECM proteins were high turnover rate glycoproteins and proteoglycans including CHAD, COCH, and KERA (Samiric et al., 2004a; Choi et al., 2020; Heinemeier et al., 2016; Tam et al., 2020). Similar findings were also identified at the 9 M post-depletion timepoint (12 M old) (Figure 2—figure supplement 1A–F).

Figure 2 with 4 supplements see all
Download asset Open asset
Scleraxis-lineage cells maintain FDL tendon homeostasis by regulating the synthesis of high turnover rate ECM proteins.

(A) Volcano plot and heatmap visualizing the significantly different protein abundances between DTR and WT groups at 3 M post-depletion. (B) Classification of all downregulated proteins between the DTR and WT FDL tendons at 3 M post-depletion. (C) Functional enrichment analysis of cellular components and molecular functions of all downregulated proteins between the DTR and WT FDL tendons at 3 M post-depletion. (D) Heatmap of all differentially abundant ECM-related proteins between the DTR and WT FDL tendons at 3 M post-depletion. (E) Classification of all ECM-related downregulated proteins between the DTR and WT FDL tendons at 3 M post-depletion. (F) Volcano plot and heatmap visualizing the significantly different protein abundances between 12 M and 6 M WT FDL tendons. (G) Classification of all downregulated proteins between 12 M and 6 M WT FDL tendons. (H) Functional enrichment analysis of all downregulated proteins between 12 M and 6 M WT FDL tendons. (I) Heatmap of all differentially abundant ECM-related proteins between 12 M and 6 M WT FDL tendons. (J) Classification of all ECM-related downregulated proteins between 12 M and 6 M WT FDL tendons. (K) Protein-protein interaction of all the downregulated proteins between DTR and WT groups at 3 M post-depletion. (L) Protein-protein interaction of all the downregulated proteins between 12 M and 6 M WT FDL tendons. (M) Heatmap with 4 ECM-related proteins that were decreased in similar rates with both natural aging and Scleraxis-lineage cell depletion. (N) Classification of the ECM-related proteins from (M).

With natural aging, 25 proteins were significantly different between the aged (12 M) and young (6 M) WT tendons (Figure 2F). Classification of all downregulated proteins in 12 M tendons determined that 28.6% were ECM proteins (Figure 2G) and functional enrichment analysis also showed that ECM-related molecular functions and cellular components were significantly impaired (Figure 2H). A total of nine decreased ECM proteins were identified in 12 M WT tendons, relative to 6 M WT (Figure 2I), and classified as proteoglycans (22.2%), glycoproteins (22.2%), ECM regulators (33.3%), and collagens (22.2%) (Figure 2J). The majority of the above ECM molecules have a high turnover rate, similar to the findings for the 3 M post-depletion timepoints (Figure 2D and E). Finally, the proteomes of aged (12 M old) WT tendons vs young (6 M old) DTR were nearly identical (Figure 2—figure supplement 2A, B). Collectively, these data further support the hypothesis that Scleraxis-lineage cell depletion in young tendons mimic impairments in ECM-related biological mechanisms that occur during natural aging.

String DB found that in DTR tendons there are two separate groups of downregulated proteins (Figure 2K), suggesting two separate mechanisms of ECM-degradation with Scleraxis-lineage depletion. With aging, three separate groups of proteins were downregulated (Figure 2L). Interestingly, proteins CHAD, ACAN, and KERA, as well as COCH and NEFL were identified also in the Scleraxis-lineage depleted vs WT (Figure 2K), suggesting that these two mechanisms are shared with both natural aging and depletion. Based on these analyses, we identified four ECM molecules (COCH, CHAD, KERA, and ACAN) that were consistently downregulated with both natural aging and Scleraxis-lineage cell depletion (Figure 2M), and demonstrated a decrease in the proportion of Coch + and Chad + cells in 6 M old DTR and 21 M old B6 tendons using single-cell RNA sequencing (Figure 2—figure supplement 3) Classification showed that 75% are proteoglycans and 25% are glycoproteins (Figure 2N). Considering the substantial changes in ECM organization and composition, we also assessed the impact of Scleraxis-lineage cell depletion and natural aging on tendon mechanical integrity (Figure 2—figure supplement 4A–D) and while there were no major changes in CSA (Figure 2—figure supplement 4B) and stiffness (Figure 2—figure supplement 4C), there was a significant decrease of tendon elastic modulus with both depletion and natural aging (Figure 2—figure supplement 4D).

Single-cell RNA sequencing demonstrates similar loss of ECM biosynthetic tenocytes as well as differential retention of ECM organizational and age-impaired tenocytes in DTR vs aged tendons.

Given that Scleraxis-lineage cell depletion in young animals induced similar declines in cell density and ECM structure-function, as well as overlapping alterations in ECM composition compared to aged WT tendons, we next asked whether the composition of the cellular environment was conserved in the context of depletion vs. natural aging. Therefore, we performed scRNAseq in 6 M old WT and DTR tendons (3 M post-DT) and 21 M old C57BL/6 J (B6) tendons. 21 M old B6 tendons were used as the ‘aged’ group as we have previously established that by this age there are age-related impairments in tissue homeostasis and tendon healing response (Ackerman et al., 2017).

In the integrated dataset, seven cell types with distinct transcriptomic signatures were identified, including tendon fibroblasts (tenocytes), epitenon cells, endothelial, nerve, and muscle cells, macrophages, and T cells (Figure 3A and B; Figure 3—figure supplement 1). Annotation of the epitenon cell cluster is based on additional work from our laboratory that will be published in a separate report (Figure 3—figure supplement 1). Considering that Scleraxis-lineage cells are tissue-resident fibroblasts (tenocytes), and these are the cells that are subject to depletion, our primary analysis focused on the impact of depletion and aging on tenocytes. We subset and re-clustered the tenocyte population (Figure 3C and D) from the integrated dataset (Figure 3A). Consistent with cellularity quantification (Figure 1), 6 M DTR and 21 M B6 tendons had a decrease in the total number of tenocytes captured compared to 6 M WT (Figure 3D and E). To decipher the biological functions of the tenocytes and assess any potential intrinsic programmatic shifts resulting from depletion or natural aging, we investigated their unique transcriptomic profiles by identifying the differentially expressed genes (DEG) between the 6 M WT, 6 M DTR, and 21 M B6 groups (Figure 3F), and performing functional enrichment analysis (FEA) based on their top 100 DEG (Figure 3G–I).

Figure 3 with 2 supplements see all
Download asset Open asset
scRNAseq demonstrates broad cellular heterogeneity and intrinsic programmatic skewing of tenocytes with depletion and natural aging.

(A) UMAP dimensionality reduction revealed seven broad and distinct cell populations on clustering based on unbiased differential gene expression of the integrated dataset. (B) Annotation marker for each of the seven cell populations identified in the FDL tendons. (C) Re-clustering of the tenocytes cell population from (A). (D) UMAP plot of tenocytes in the integrated data colored based on respective group (pink: 21 M old B6, green: DTR 6 M old, blue: WT 6 M old). (E) Quantification of the percentage of tenocytes normalized by the total cells captured per condition. (F) Heatmap with the top 40 significantly expressed genes in tenocytes per condition. (G) Significantly upregulated biological processes of tenocytes in the 6 M WT (G), 6 M DTR (H), and 21 M B6 (I). Dotted lines in G, H, and I indicate statistical significance of adjusted p-value <0.05 (-log10(adj. p-value = 1.3)).

Tenocytes in the 6 M WT group express genes related primarily to ECM biosynthetic process and secondary to ECM organization such as Col1a1, Col1a2, Tnxb, Coch, Col11a2, and Fbln1. Based on FEA, 6 M WT tenocytes are broadly characterized as ECM biosynthetic (‘translation’, ‘macromolecule biosynthetic process’, ‘collagen metabolic process’) and ECM organizational (‘ECM organization’, ‘homeostatic process’, ‘collagen fibril organization’)(Figure 3F and G). Consistent with our proteomics findings, broadly, both DTR and aged tenocytes exhibited a decrease in processes related to ECM biosynthesis such as ‘translation’, ‘biosynthetic process’, ‘cell and macromolecule biosynthetic process’ (Figure 3F–I). Interestingly, tissue resident macrophages from aged (21 M B6 tendons) demonstrate similar shifts in biological processes, relative to 6 M WT cells, including enrichment for functions associated with ‘protein refolding’, and ‘response to unfolded proteins’ (Figure 3—figure supplement 2). To better understand tenocyte heterogeneity as well as the similar shifts of tenocyte biological processes in DTR and natural aging, we subsetted and re-clustered the tenocyte cluster, which resulted in three distinct subpopulations (Figure 4A), and then examined the distribution of these subsets among the different groups (6 M WT, 6 M DTR, 21 M B6) (Figure 4B–E). With both depletion and aging, we found that tenocytes 1 were decreased to almost identical levels. Specifically, tenocytes 1 subpopulation exhibited a 75.18% decrease with depletion and a 78.9% decrease with aging (Figure 4B–E). FEA analysis demonstrated that tenocytes 1 express biological processes related to ECM biosynthesis (‘biosynthetic process’, ‘collagen biosynthetic’ and ‘collagen metabolic process’) and immune response (‘inflammatory’ and ‘immune response’, ‘response to IL1’, ‘T cell activation’) (Figure 4F and G). Finally, we identified Gbp2 as a specific marker of tenocytes 1 (Figure 4J) and found that with both depletion and natural aging there was a decrease in Gbp2+ + compared to the 6 M WT (Figure 4J). Staining for GBP2 protein validated our scRNAseq results and showed a 58.66% (p<0.0001) and a 44.54% (p<0.0001) decrease in GBP2+ + with depletion and natural aging relative to the 6 M WT group (Figure 4K and L). Taken together, our scRNAseq results demonstrate that the consistent loss of ECM biosynthetic tenocytes 1 in young DTR and aged groups is the main driver for impaired tendon homeostasis.

Figure 4
Download asset Open asset
DTR and aged tendons lose tenocytes associated with ECM biosynthesis and immune surveillance, while DTR tendons retain tenocytes associated with ECM organization and remodeling.

(A) UMAP plot of all three tenocytes subpopulations. (B) UMAP plot showing the shifts of tenocytes 1–3 with depletion and natural aging. (C–E) Quantification of % in tenocytes 1 (C), tenocytes 2 (D), and tenocytes 3 (E), in the 6 M WT, DTR, and 21 M B6 groups (F) Heatmap with the top 40 significantly expressed genes per tenocyte subcluster. (G–I) Significantly upregulated biological processes of tenocytes 1 (G), tenocytes 2 (H), and tenocytes 3 (I), respectively. (J) UMAP feature plot of Gbp2+ + and their shift with depletion and natural aging, respectively. (K) Representative IF of protein validation on the decrease in GBP2 +tenocytes 1 cells with Scleraxis-lineage cell depletion and natural aging. (L) Quantification of IF for GBP2 + cell density in 6 M WT, 6 M DTR, and 31 M B6 groups. Data are presented as mean ± standard deviation.

Besides the consistent decrease of ECM biosynthetic tenocytes with DTR and aging, we also identified divergent retention of the remaining tenocytes between DTR and aged groups (Figure 3F–I). Broadly, tenocytes in the 6 M DTR group express genes related ECM organization, development and remodeling such as Edil3, Mmp2, Col5a1 and Fn1. Based on FEA, 6 M DTR tenocytes are characterized as specialized cells for ECM organization and remodeling (‘ECM organization’, ‘extracellular structure organization’ ‘supramolecular fiber organization’, and ‘tissue remodeling’). In contrast, tenocytes from 21 M B6 mice express genes related to hallmarks of aging like loss of proteostasis (Ppp1r15a, Hspa8, Hsp90aa1, Hspa5, Hspb1, Hspa1, Hspa1b, and Dnajb9) and inflammaging (Il6, Stat3, Tnfaip3, Cxcl12, and Bcl3). Indeed, FEA of 21 M B6 tenocytes demonstrated processes related to ‘response to stress’, ‘response to unfolded protein’, ‘T cell and leukocyte activation’, ‘TNF and IL1 production’, and ‘aging’ (Figure 3F1). Further analysis showed that in the DTR group there was a retention of tenocytes 2, while this population was decreased by 96.2% in the aged WT tendon relative to the young WT (Figure 4B–E). Tenocytes 2 express genes that give rise to ECM proteins such as Mmp2, Lum, Col1a1, Col3a1, Col11a1, and Mfap5. FEA demonstrated biological processes such as ‘ECM and collagen fibril organization’, ‘supramolecular fiber organization’, ‘cell adhesion’, and ‘wound healing’, suggesting that tenocytes 2 exhibit functions related to ECM organization and wound healing (Figure 4F and H). Taken together, these divergent retention of tenocytes in DTR and aged tendons might dictate divergent healing responses after injury.

In addition to divergence of tenocyte subpopulations shifts, we also assessed for potential intrinsic programmatic shifts of tenocytes 1 and 2 with DTR and natural aging by comparing the transcriptomic profile of tenocytes 1 with DTR and aging (Figure 5A–J), as well as the transcriptomic profile of tenocytes 2 in the 6 M WT vs 6 M DTR groups (Figure 5K–O). In DTR compared to WT tendons, tenocytes 1 exhibited a total of 413 DEG (Figure 5A and B). FEA revealed that tenocytes 1 in the 6 M WT group exhibited processes such as ‘translation’, ‘macromolecule biosynthetic process’, ‘structure morphogenesis’, while in the 6 M DTR group, tenocytes 1 exhibited processes such as ‘cell migration’, ‘ECM organization’, and ‘wound healing’ (Figure 5C–E). In contrast, looking at age-related programmatic shifts of tenocytes 1 (Figure 5F–H), while young WT tenocytes 1 exhibited processes such as ‘collagen biosynthesis’, ‘ECM organization’, and ‘immune cell chemotaxis’ (Figure 5I), aged tenocytes 1 exhibited processes related to potential indicators of aging hallmarks such as loss of proteostasis ‘response to unfolded protein’, ‘protein refolding’, and ‘inflammaging’ ‘T cell activation’, ‘immune response’ (Figure 5J). Regarding programmatic changes of tenocytes 2 in 6 M WT vs DTR (Figure 5K), FEA analysis from the DEGs (Figure 5L and M) showed that tenocytes 2 in the young WT tendons exhibited biological processes such as ‘macromolecule biosynthetic and metabolic processes’, ‘collagen metabolic processes’, and ‘ECM organization’, while tenocytes 2 in the young DTR group exhibited further elevated as well as new processes related to matrix organization and remodeling such as ‘ECM organization’, ‘extracellular fibril organization’, and ‘ECM assembly’ (Figure 5N and O). These divergent intrinsic programmatic shifts in tenocytes between DTR and aged tendons might also dictate the divergent healing responses that are observed in these models.

Figure 5
Download asset Open asset
Tenocytes 1 and 2 become more ECM organizational in DTR tendons while tenocytes 1 exhibit indications of aging hallmarks such as loss of proteostasis and inflammaging.

(A) UMAP plot of tenocytes 1 in 6 M WT and DTR groups. (B) Volcano plot visualizing all the significantly different genes in tenocytes 1 between 6 M WT vs. 6 M DTR. Blue dots indicate genes that are down-regulated in DTR vs WT, while red indicates genes up-regulated in DTR vs. WT. (C) Heatmap of the top 50 differentially expressed genes of tenocytes 1 between 6 M WT and DTR groups. (D) Biological processes up regulated in 6 M WT tenocytes 1. (E) Biological processes upregulated in 6 M DTR tenocytes 1. (F) UMAP plot of tenocytes 1 in 6 M WT and 21 M B6 groups. (G) Volcano plot visualizing all the significantly different genes of tenocytes 1 between 6 M WT and 21 M B6. Blue dots indicate genes that are down-regulated in 21 M B6 vs. 6 M WT, while red indicates genes up-regulated in 21 M B6 vs. 6 M WT. (H) Heatmap of the top 50 differentially expressed genes of tenocytes 1 between 6 M and 21 M B6 groups. (I) Biological processes of tenocytes 1 in 6 M WT group. (J) Biological processes of tenocytes 1 in 21 M B6 group. (K) UMAP plot of tenocytes 2 in 6 M WT and 6 M DTR groups. (L) Volcano plot visualizing all the significantly different genes of tenocytes 2 between 6 M WT vs. 6 M DTR. Blue dots indicate genes that are down-regulated in DTR vs WT, while red indicates genes up-regulated in DTR vs. WT. (M) Heatmap of the top 50 differentially expressed genes of tenocytes 2 between 6 M WT and 6 M DTR groups. (N) Biological processes upregulated in 6 M WT Tenocytes 2. (O) Biological processes upregulated in 6 M DTR Tenocytes 2.

Tenocyte autocrine and paracrine signaling is differentially altered with Scleraxis-lineage depletion vs. natural aging

Cellular communication is crucial for maintenance of tissue homeostasis (Bissonnette et al., 2020; Lee and Schwarz, 2020; Franklin, 2021; Mattes and Scholpp, 2018; Park et al., 2017), and physiological communication patterns are impaired with aging, leading to disruptions tissue health (López-Otín et al., 2013; Robert and Fulop, 2014). Therefore, we next determined what the predominant tenocyte communication patterns are in young WT tendon, and how these patterns are changed in the contexts of depletion and natural aging.

Young WT tenocytes 1–3 exhibit both autocrine and paracrine signaling (Figure 6—figure supplement 1A, B) Tenocytes 1 exhibit high communication strength as both sender and receiver, tenocytes 2 is the predominant sender but exhibits low intercellular communication strength as a receiver and tenocytes 3 exhibits high communication strength as a receiver but low strength as a sender (Figure 6—figure supplement 1C, D). Scleraxis-lineage cell depletion resulted in substantial shifts in tenocyte autocrine and paracrine communication (Figure 6A–F). Tenocytes 1 exhibited a decrease in overall communication, tenocytes 2 exhibited an increase in autocrine and paracrine signaling to tenocytes 1, but a decrease in paracrine signaling to tenocytes 3. Finally, tenocytes 3 demonstrated a decrease in autocrine and paracrine signaling to tenocytes 1, and an increase in paracrine signaling to tenocytes 2 (Figure 6B). Five signaling pathways (CHAD, LIFR, NECTIN, CADM, EPHA) were identified exclusively in the 6 M WT group, while four signaling pathways (IL6, SEMA3, NOTCH, and FGF) were expressed only in the 6 M DTR group (Figure 6C). The heatmaps demonstrate the strength of outgoing (Figure 6D), and incoming (Figure 6E) signaling patterns in tenocytes. We further focused on the THBS signaling pathway since Thbs2, Thbs3, and Comp were significantly decreased with depletion in both the proteomics and scRNAseq datasets (Figure 2A and D; Figure 6—figure supplement 1). More specifically, we identified that Thbs3-Sdc1, Thbs2-Sdc4, Thbs2-Sdc1, and Thbs2-Cd47 ligand-receptor interactions were decreased in tenocytes 1–3 with depletion (Figure 6F), suggesting that this interaction may be important for maintenance of tendon homeostasis.

Figure 6 with 1 supplement see all
Download asset Open asset
Tenocyte-tenocyte communication is impaired with both Scleraxis-lineage cell depletion and natural aging.

(A) UMAP plot of tenocytes subpopulations in the 6 M WT and DTR groups. (B) Differential number of cell-cell interactions of tenocytes 1–3 in the 6 M WT and DTR groups (red color indicates an increase and blue color indicates a decrease in cell communication with Scleraxis-lineage cell depletion relative to WT, respectively; arrow indicates the communication between two different cells and the direction of the arrow indicates the cell that expresses the ligand vs the cell that expresses the receptor, where the pointed cell by the arrow is the receiver). (C) All the signaling pathways that were identified in the 6 M WT and DTR groups (pathways highlighted with orange color indicate those that were expressed only or higher in the 6 M WT relative to 6 M DTR group; pathways highlighted with green color indicate those that were expressed only or higher in the 6 M DTR relative to 6 M WT group). (D) Heatmap with all the outgoing signaling patterns for tenocytes 1–3 for the 6 M WT and DTR groups. (E) Heatmap with all incoming signaling patterns for tenocytes 1–3 for the 6 M WT and DTR groups. (F) THBS signaling-related ligand-receptor interactions that take place in the 6 M WT and DTR groups. (G) UMAP plot of tenocytes subpopulations in the 6 M WT and 21 M B6 groups. (H) Differential number of cell-cell interactions of tenocytes 1 and 2 in the 6 M WT and 21 M B6 groups (blue color indicates a decrease in cell communication with natural aging relative to WT); arrow indicates the communication between two different cells and the direction of the arrow indicates the cell that expresses the ligand vs the cell that expresses the receptor, where the pointed cell by the arrow is the cell that expresses the receptor or in other words the receiver (I) All the signaling pathways that were identified in the 6 M WT and 21 M B6 groups (pathways highlighted with orange color indicate those that were expressed only or higher in the 6 M WT relative to the 21 M B6 group; pathways highlighted with green color indicate those that were expressed only or higher in the 21 M B6 groups relative to 6 M WT group). (J) Heatmap with all the outgoing signaling patterns for tenocytes 1 and 2 for the 6 M WT and 21 M B6 groups. (K) Heatmap with all incoming signaling patterns for tenocytes 1 and 2 for the 6 M WT and 21 M B6 groups. (L) THBS signaling-related ligand-receptor interactions that take place in the 6 M WT and 21 M B6 groups.

In contrast to altered communication in response to DTR, natural aging results in an almost complete loss in tenocyte communication compared to 6 M WT (Figure 6G–L). Tenocytes 1 and 2 exhibited a loss of both autocrine and paracrine communication (Figure 6H). A majority of the signaling pathways were expressed only in the 6 M WT group, suggesting that with natural aging there is a substantial and widespread loss of tenocyte-tenocyte communication (Figure 6I–K). Interestingly, SPP1 and WNT pathways were present only in the aged group in both an outgoing and incoming pattern (Figure 6J and K). Finally, we also identified a loss of THBS signaling with natural aging, including Thbs3-Sdc4, Thbs3-Sdc1, Thbs2-Sdc4, Thbs2-Sdc1, and Thbs2-Cd47 (Figure 6L), which was very similar to the ligand-receptor interactions lost with depletion (Figure 6F). Taken together, aging results in broad decline in tenocyte-tenocyte communication, and future work will define whether decreased and altered communication between the remaining tenocytes may drive further degeneration beyond that observed at 21 M B6.

Discussion

Aging impairs tendon homeostasis, increases the risk of degeneration (Riel et al., 2019; Teunis et al., 2014) and the frequency of injury, and diminishes healing capacity after injury (Ackerman et al., 2017; Teunis et al., 2014; Houshian et al., 1998). In addition, clinical studies have shown that age-related tendon changes are associated with impaired dynamic stability and increased risk of falling, factors that significantly increase both morbidity and mortality (Onambele et al., 2006; Tomlinson et al., 2021; Karamanidis et al., 2008). In this study, we identified the cell and molecular mechanisms that maintain tendon homeostasis during adulthood and demonstrate how these mechanisms are disrupted with aging. Moreover, we demonstrated that depletion of Scleraxis-lineage cells in the adult tendon mimics age-related impairments in cellular density, ECM structure, composition, and material quality. By comparing these two models, we were able to delineate the mechanisms that regulate tendon homeostasis, independent of the systemic effects of aging, while also establishing the tendon-specific response to aging. More specifically, we have demonstrated that loss of a critical mass of biosynthetic tenocytes, or biosynthetic tenocyte function initiates a degenerative cascade in tendon. This is particularly striking as it demonstrates that it is the decline in cell density and the accompanying loss of cell function itself that drives age-related tendon degeneration, rather than age-related programmatic shifts. Finally, these data provide more granular information on the timeline in which age-associated declines in tendon cell density occur and provide a functional and mechanistic link between declines in tendon cell density and initiation of tendon degeneration. Moreover, we have identified preventing the loss of biosynthetic tenocytes (whether via apoptosis or other mechanisms) as a critical intervention point for maintaining tendon structure-function.

While we have previously shown that this Scleraxis-lineage depletion strategy results in a ~60% decrease in tendon cell density (Best et al., 2021), it was unknown whether this was a sustained or transient depletion event that eventually results in re-population of the tendon via compensation by non-depleted populations. Indeed, this model results in sustained cell depletion, thus allowing assessment of the long-term impact of Scleraxis-lineage cell deficiency. It is important to note that this model likely depletes any ‘progenitor’ cell populations due to the use of non-inducible Scx-Cre, further inhibiting any potential cellular rebounding post-depletion. We observed that Scleraxis-lineage cell depletion resulted in almost identical cellular density with older (12 M old) and geriatric (31 M old) tendons, indicating that with depletion, there is an acceleration of the natural age-related tendon cell loss. An age-related decline in tendon cell density has been extensively documented, with consistent decreases across anatomically distinct tendons and animal models (Korcari et al., 2023; Sugiyama et al., 2019; Stanley et al., 2007; Yan et al., 2020; Freedman et al., 2022). However, the fact that Scleraxis-lineage depletion in young animals results in a comparable decline in cellularity suggests there may be mechanisms that maintain a minimum level of cellularity and prevents complete cell loss, although these mechanisms remain to be defined. Moreover, the recapitulation of many established hallmarks of tendon aging, including altered ECM structure, organization, and material quality (Connizzo et al., 2013; Gehwolf et al., 2016; Dunkman et al., 2013; Sugiyama et al., 2019; Ippolito et al., 1980; Watanabe et al., 1994; Watanabe et al., 1997), further supports the utility of defining the consistent underlying mechanisms between DTR and aging to define previously unappreciated drivers of age-related tendon pathology. Indeed, the combination of transcriptomic and proteomic analyses in these models has facilitated identification of the key alterations in ECM composition that are associated with initiation and progression of tendon degeneration. Consistent with declines in high-turnover rate proteoglycans and glycoproteins with aging in other tissues (Choi et al., 2020; Ewald, 2020; Ariosa-Morejon et al., 2021; McCabe et al., 2020), these classes of proteins were decreased in both aged and young depleted tendons, demonstrating that Scleraxis-lineage cells are required to directly regulate the synthesis and maintenance of multiple GPs and PGs, which are crucial to maintain tendon structure-function, since their decrease results in significantly impaired collagen fibril organization and biomechanical properties. While other studies have shown through genetic KO models, that high turnover rate GPs and PGs are required to maintain tissue (tendon, bone, cartilage, skin) homeostasis during adulthood (Watanabe et al., 1994; Watanabe et al., 1997; Batista et al., 2014; Hessle et al., 2014; Pöschl et al., 2004; Cosgrove et al., 1996; Hecht et al., 1995; Geng et al., 2008; Tiedemann et al., 2013; Sakai et al., 2016; Dex et al., 2017; Barbier et al., 2014; Kokenyesi et al., 2004; Qabar et al., 1994), they have been primarily descriptive. In contrast, we demonstrate that Scleraxis-lineage cells are a ‘master-regulator’ of multiple ECM-related proteins during tendon homeostasis. More specifically, we identified decreased expression of COCH and CHAD protein in the tendon ECM in these models, as well as a consistent decline in Coch + and Chad + cells. Interestingly, COCH expression is observed in the spiral ligament of the inner ear, and Coch-/- results in degeneration of this ligament (Kommareddi et al., 2007), further supporting the potential importance of this molecule in maintenance of tendon structure.

Consistent with prior scRNAseq studies in mouse and human tendons (De Micheli et al., 2020; Kendal et al., 2020; Kaji et al., 2021), we have identified substantial heterogeneity of the tendon cell environment. We have further built on this by establishing the functional consequences of decreasing the subpopulation that is primarily characterized by ECM biosynthetic functions. Interestingly, age-related declines in ECM biosynthetic function have also been identified in mouse and human skin fibroblasts (Solé-Boldo et al., 2020; Salzer et al., 2018), thus, future work will focus on establishing and disrupting the mechanisms that drive age-related declines in biosynthetic tenocyte number and function. In addition, we found that Guanylate binding protein 2 (GBP2) was a unique marker for the biosynthetic tenocytes 1, allowing us to track and identify this tenocyte biosynthetic subpopulation. While there are no studies that have assessed the function of GBP2 in tendon, other studies have shown that GBP2 exhibits host-defense and anti-microbial functions (Tretina et al., 2019; Kutsch and Coers, 2021). Based on the innate immune and defense response BPs of tenocytes 1, in addition to their biosynthetic capacity, it could be speculated that this subpopulation may play a role in the immune defense response of tendons after injury. Since tenocytes 1 decreases with aging, it might drive additional tendon intrinsic immune dysregulation after an injury, further impeding the healing capacity of aged tendons. However, future studies are needed to define the function of GBP2 in tendon cells. As such, GBP2 is exclusively used as a marker of Tenocytes 1 in this study. Finally, our CellChat analyses identified that Thbs2-Sdcn4 signaling was significantly impaired with both DTR and aging, suggesting that this pathway might be important for maintenance of tendon homeostasis. While this specific pathway has not been extensively studied in tendon, previous work has shown that Sdcn4 is required for muscle development, homeostasis, and healing after injury (Cornelison et al., 2004; Rønning et al., 2020). As such, future studies can better define the role of this signaling axis in tendon health, as it may represent promising therapeutic target.

In addition to comparable declines in biosynthetic function and subsequent initiation of tendon degeneration in these models, there are several informative areas of divergence. First, the tenocytes that remain in aged tendons demonstrate programmatic skewing, including an increased pro-inflammatory signature and loss of proteostasis. While these shifts are not necessary for homeostatic disruption, as evidenced by comparable disruptions in DTR tendons in the absence of this skewing, it is possible that these changes drive subsequent degeneration at timepoints beyond those included in this study. Consistent with this, 31 M B6 tendons exhibit substantial increases in ECM disorganization, relative to DTR. Moreover, while no enrichment of senescent markers was observed in aged tenocytes, it is possible that the pro-inflammatory signature and loss of proteostasis may be a precursor to subsequent tenocyte senescence, which could be an important driver of additional tendon degeneration. Finally, in addition to the unique programmatic shifts observed in aged tenocytes vs. the young depletion model, aged tendon resident macrophages demonstrate similar shifts in biological processes toward a response to protein unfolding, suggesting this may be a conserved feature of tendon cell natural aging. Another intriguing consideration is how these divergent shifts in tenocyte programs may relate to the divergent healing outcomes observed between these models (Figure 7). Consistent with impaired healing capacity in many aged tissues (Ackerman et al., 2017; Browder et al., 2022; Sgonc and Gruber, 2013; Yamaguchi et al., 2021), we have previously shown that 22 month-old tendons heal in a mechanically inferior manner, relative to young tendons, and fail to form the provisional ECM needed for successful healing (Ackerman et al., 2017). Thus, establishing how these intrinsic programmatic shifts may impair specific aspects of the healing process will be necessary to develop strategies to rescue the aged tendon healing process. In contrast, the cells that remain in DTR tendons display programmatic shifts associated with enhanced remodeling capacity. Moreover, DTR tendons demonstrate improved healing capacity relative to age-matched WT repairs (Best et al., 2021). As such, understanding the signals that drive this programmatic shift in DTR, and establishing the mechanisms by which Scleraxis-lineage cell depletion enhances tendon healing holds tremendous potential for tendon tissue engineering and therapeutic strategies. Finally, these data highlight the surprising finding that homeostatic disruptions including decreased cell density and altered ECM composition, quality and organization are not of central relevance to the quality of the tendon healing response, suggesting a de-coupling of the mechanisms that regulate homeostasis and healing capacity.

Figure 7
Download asset Open asset
Schematic highlighting key findings and proposed models for divergent healing responses in young depleted vs aged tendons.

Both young DTR and aged WT tendons have similar decreases in tissue structure, organization, material quality, and total cell density. They also follow the same mechanism of ECM degeneration via a substantial decrease in the number of proteoglycans and glycoproteins with high turnover rate. However, in terms of cell composition shifts with depletion and natural aging, young DTR tendons are comprised mainly of tenocytes specialized in tissue organization and remodeling. What is more, young DTR have little to no inflammatory/reactive tenocytes. In contrast, old WT tendons are comprised predominantly of inflammatory and age-related functionally impaired tenocytes and exhibit little to no presence of tissue remodeling tenocytes. We speculate that these significantly different cellular compositions are some of the main causes resulting in divergent healing responses, with young DTR tendons showing improved healing while old WT tendons exhibiting impaired healing response.

One limitation of the study is that the Scx-Cre; DTR F/+ targets all Scleraxis-lineage cells, and the Scleraxis-lineage is known to contribute to tissues in addition to tendon (e.g. bones and muscle) (Agarwal et al., 2017; Yoshimoto et al., 2017). However, our initial plans to deplete Scleraxis-lineage cells by utilizing the inducible Scx-CreERT2 crossed to the diphtheria toxin A-subunit gene (DTA) mouse model, resulted in insufficient cell depletion. Scx-CreERT2; Rosa-DTR mice could be an alternative to inducibly deplete only adult Scleraxis-lineage cells, although this model requires both TMX and DT administration, and discrepencies in labelling vs. depletion may be observed. In addition, while we clearly demonstrate programmatic skewing in aged (21 M) tendons, relative to young, it is not clear when cells begin to undergo this programmatic shift. Future work to define the temporal nature will the establish the onset of these shifts as an additional important intervention point for maintaining physiological tendon cell function.

In summary, our morphological and multi-omics analyses identified Scleraxis-lineage cell depletion as a novel model of accelerated tendon ECM aging based on comparable changes in ECM organization, composition, and material quality with aged tendons. Moreover, we defined loss of a critical mass of biosynthetic tenocyte function as a conserved initiator of disrupted tendon homeostasis and degeneration in both young and aged animals. Thus, identifying strategies to prevent apoptosis of this population is an important priority for maintaining tendon health through the lifespan. Finally, we have demonstrated divergent programmatic skewing between Scleraxis-lineage cell depletion in young animals, and natural aging, and suggest that these differences may underpin the divergent healing capacity observed in these models. Therefore, it will be necessary to develop different strategies to address or prevent these two distinct manifestations of aging in the tendon to preserve both tendon homeostasis and healing capacity.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Genetic reagent
(Mus. musculus)		Scx-CreDr. Ronen Schweitzer
Genetic reagent
(Mus. musculus)		C57BL/6-Gt(ROSA)26S
ortm1(HBEGF)Awai/J
(Rosa-DTRLSL)		Jackson LaboratoryStock #: 007900Referred to as DTR in manuscript
RRID:IMSR_JAX:007900
Genetic reagent
(Mus. musculus)		C57Bl/6 JJackson LaboratoryStock #: 000664Referred to as B6 in manuscript
RRID:MGI:2159769
AntibodyAnti-rabbit Rhodamine-
Red-X
(donkey polyclonal)		Jackson
ImmunoResearch		Catalog #: 711-296-1521:200
RRID:AB_2340614
AntibodyAnti-GBP2
(rabbit polyclonal)		ProteintechCatolog #: 11854–1-AP1:500
RRID: AB_2109336
Chemical
Compound, Drug		Diphtheria Toxin (DT)Millipore SigmaCatalog #: D0564-1MG20 ng DT / injection
Software,
algorithm		GraphPad Prism
software		GraphPad Prismhttps://graphpad.comVersion 9.5
Software,
algorithm		OlyVIA softwareOlympushttps://www.olympus-lifescience.com/en/support/downloads/Version 2.9
Software,
algorithm		ImageJ softwareImageJhttp://imagej.nih.gov/ij/
Software,
algorithm		R studioR Studiohttps://www.rstudio.com
Software,
algorithm		DAVID Gene Functional Classification ToolHuang et al., 2009
https://david.ncifcrf.gov/Version 6.8
Software,
algorithm		CellChatJin et al., 2021http://www.cellchat.orgVersion 1.1.3
Software,
algorithm		Seurat R packageStuart et al., 2019https://www.rdocumentation.org/packages/Seurat/versions/4.1.0Version 4.0
Software,
algorithm		Discoverer software
platform		Thermo FisherVersion 2.4
Software,
algorithm		PANTHER classification
system		Mi et al., 2021
http://pantherdb.org/
Software,
algorithm		Search Tool for Retrieval of Interacting Genes/
Proteins (STRING)		Szklarczyk et al., 2019v11.0
Software,
algorithm		MatrisomeDBHynes and Naba, 2012.https://web.mit.edu/hyneslab/matrisome/
Software,
algorithm		CellMarker softwareZhang et al., 2019http://bio-bigdata.hrbmu.edu.cn/CellMarker/search.jsp
OtherGene Expression
Omnibus (GEO)		Accession # GSE214929Single-cell RNA
sequencing data
OtherProteomeXchange
Consortium		Dataset Identifier: PXD037230Proteomics data

Mice

All animal studies were approved by the University Committee for Animal Resources (UCAR) and in compliance with ARRIVE guidelines. Scx-Cre mice were generously provided by Dr. Ronen Schweitzer. ROSA26-iDTRF/F (#007900) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Scx-Cre mice were crossed to ROSA26-iDiphtheria Toxin ReceptorLox-STOP-Lox (DTRF/F) mice to generate a model of Scleraxis-lineage tendon cell depletion (Scx-Cre+; DTRF/+; referred to as DTR). Expression of DTR is inhibited prior to Cre-mediated recombination due to the presence of a STOP cassette flanked by loxP sites (Lox-STOP-Lox). After Cre-mediated recombination, the STOP cassette is deleted, resulting in expression of DTR, specifically in Scleraxis-lineage cells. Thus, administration of diphtheria toxin (DT) in these mice results in apoptosis of Scleraxis-lineage cells. Scx-Cre-; DTR F/+ (WT) littermates were used as controls. DT was administered for 5 consecutive days in the hind paws of both DTR and WT mice at three months of age. Male and female mice were used for all studies. C57BL/6 J mice (B6; #664, Jackson Laboratory) were used for natural aging studies as noted. All mouse work (injections, surgeries, harvests) were performed in the morning. Mice were kept in a 12 hr light/dark cycle.

Paraffin histology and immunofluorescence

Request a detailed protocol

Sections were stained with DAPI to visualize nuclei and imaged using a VS120 Virtual Slide Microscope (Olympus, Waltham, MA). Using ImageJ (Schneider et al., 2012), a region of interest (ROI) was drawn at the tendon midsubstance and the area of the ROI was calculated. Nuclei within the ROI were manually counted, and total nuclei number was normalized to area. An n=5–7 mice per group were used for quantification. Five-micron paraffin sagittal sections of 6 M WT, 6 M DTR, and 31 M C57BL/6 J hind paws were cut. For immunofluorescence, sections were stained with an anti-GBP2 antibody (1:500, Proteintech Cat#: 11854–1-AP, RRID: AB_2109336), followed by a Donkey anti-rabbit Rhodamine-Red-X secondary antibody (1:200, Jackson ImmunoResearch, #711-296-152, RRID: AB_2340614). Sections were counterstained with DAPI to visualize nuclei and imaged using a VS120 Virtual Slide Microscope (Olympus, Waltham, MA). GBP2 + cells and total nuclei within the ROI were manually counted and the number of GBP2 + cells was normalized by the total nuclei number to quantify the percent of GBP2 + cells. All quantification was conducted in a blinded manner. An n=6–8 mice per group were used for quantification.

Second harmonic generation two-photon confocal imaging

Request a detailed protocol

Five-micron paraffin sections of DTR, WT, and C57BL/6 J hind paws were utilized for second harmonic generation (SHG) imaging. Sections were scanned with a Spectra-Physics MaiTai HP DeepSee Ti:Sapphire Laser, tuned to 1000 nm, under ×25 magnification, 2.5 X optical zoom, and step size of 0.25 mm. 3D projections of image stacks were generated using the 3D-Project macro in ImageJ and analyzed for collagen fibril uniformity using the built-in Directionality macro function. The Directionality (dispersion) macro utilizes Fourier transform analysis to derive spatial orientation of image stacks (Lobo et al., 2015). Sections were analyzed from n=3–5 mice per group per age.

Quantification of biomechanical properties

Request a detailed protocol

DTR and WT and C57BL/6 J FDL tendons were harvested from the hind paws. Specifically, each FDL tendon was carefully separated at the myotendinous junction under a dissecting microscope. The tarsal tunnel was then cut and the FDL tendon was slowly released from the tarsal tunnel, isolated until the bifurcation of the digits and then cut and released. Under the dissecting microscope, any additional connective tissues (e.g., muscle) were removed and the FDL tendon was prepared for uniaxial testing. Two pieces of sandpaper were placed on each end of the tendon and glued together using cyanoacrylate (Superglue, LOCTITE). All the steps above were performed with the tissue periodically submerged in PBS to avoid any potential tissue drying. Each gripped tendon was transferred into a semi-customized uniaxial microtester (eXpert 4000 MicroTester, ADMET, Inc, Norwood MA). The microtester, along with the sample, was transferred to an inverted microscope (Olympus BX51, Olympus) to visualize the tendon and quantify the gauge length, width, and thickness. The gauge length of each sample was set as the end-to-end distance between opposing sandpaper edges and was set the same for all samples tested. The cross-section of the tendon was assumed to be an ellipse, where the width of the tissue represents the major axis and the thickness of the tissue represents the minor axis. Based on the optically measured width and thickness of each tendon, the area of the elliptical cross-section was computed. After measurement of the tendon’s gauge length, a uniaxial displacement-controlled stretching of 1% strain rate until failure was applied. Load and grip-grip displacement data were recorded and converted to stress-strain data, and the failure mode was tracked for each mechanically tested sample. The load-displacement and stress-strain data were plotted and analyzed to determine structural (stiffness) and material (modulus) properties. Specifically, the slope of the linear region from the load displacement graph was determined to be the stiffness of the tested sample. The slope of the linear region from the stress-strain graph was taken to equal the elastic modulus parameter of each tested tendon. Note that this calculation assumes that stress and strain are uniform within each specimen. A sample size of n=7 animals per group was utilized for biomechanical testing and analysis.

Sample preparation for mass spectrometry

Request a detailed protocol

Homogenization of each tendon tissue was performed by adding 150 μL of 5% Sodium Dodecyl Sulphate (SDS), 100 mM Triethylammonium bicarbonate (TEAB). Samples were vortexed and then sonicated (QSonica) for 5 cycles, with a 1 min resting period on ice after each cycle. Lysates were then centrifuged at 15,000 x g for 5 min to collect cellular debris, and the supernatant was collected. Next, the total protein concentration was determined by bicinchoninic acid assay (BCA; Thermo Scientific), after which samples were diluted to 1 mg/mL in 5% SDS, 50 mM TEAB. A mass of 25 µg of protein from each sample was reduced with dithiothreitol to 2 mM, followed by incubation at 55 °C for 60 min. Iodoacetamide was added to 10 mM and incubated for 30 min in the dark at room temperature to alkylate the proteins. Phosphoric acid was added to 1.2%, followed by six volumes of 90% methanol, 100 mM TEAB. The resulting solution was added to S-Trap micros (Protifi) and centrifuged at 4000 x g for 1 min. S-Traps with the trapped protein were washed twice by centrifuging through 90% methanol, 100 mM TEAB. One µg of trypsin was brought up in 20 μL of 100 mM TEAB and added to the S-Trap, followed by 20 µL of TEAB to ensure the sample did not dry out. The cap to the S-Trap was loosely screwed on but not tightened to ensure the solution was not pushed out of the S-Trap during digestion. Samples were placed in a humidity chamber at 37 °C overnight. The next morning, the S-Trap was centrifuged at 4000 x g for 1 min to collect the digested peptides. Sequential additions of 0.1% Trifluoroacetic acid (TFA) in acetonitrile and 0.1% TFA in 50% acetonitrile were added to the S-trap, centrifuged, and pooled. Samples were frozen and dried down in a Speed Vac (Labconco), then re-suspended in 0.1% trifluoroacetic acid prior to analysis. Three tendons per genotype per timepoint were used for proteomic analysis.

Mass spectrometry (MS)

Request a detailed protocol

Peptides were injected onto a homemade 30 cm C18 column with 1.8 µm beads (Sepax), with an Easy nLC-1200 HPLC (Thermo Fisher), connected to a Fusion Lumos Tribrid mass spectrometer (Thermo Fisher). Solvent A was 0.1% formic acid in water, while solvent B was 0.1% formic acid in 80% acetonitrile. Ions were introduced to the MS using a Nanospray Flex source operating at 2 kV. The gradient began at 3% B and held for 2 min, increased to 10% B over 6 min, increased to 38% B over 95 min, then ramped up to 90% B in 5 min and was held for 3 min, before returning to starting conditions in 2 min and re-equilibrating for 7 min, for a total run time of 120 min. The Fusion Lumos was operated in data-dependent mode, with MS1 scans acquired in the Orbitrap, and MS2 scans acquired in the ion trap. The cycle time was set to 2 s. Monoisotopic Precursor Selection (MIPS) was set to Peptide. The full scan was done over a range of 375–1400 m/z, with a resolution of 120,000 at m/z of 200, an AGC target of 4e5, and a maximum injection time of 50 ms. Peptides with a charge state between 2 and 5 were picked for fragmentation. Precursor ions were fragmented by collision-induced dissociation (CID) using a collision energy of 30% with an isolation width of 1.1 m/z. The Ion Trap Scan Rate was set to Rapid, with a maximum injection time of 35ms, an AGC target of 1e4. Dynamic exclusion was set to 45 s.

MS data filtering

Request a detailed protocol

Raw data was searched using the SEQUEST search engine within the Proteome Discoverer software platform, version 2.4 (Thermo Fisher), using the SwissProt Mus musculus database. Trypsin was selected as the enzyme allowing up to 2 missed cleavages, with an MS1 mass tolerance of 10 ppm, and an MS2 mass tolerance of 0.6 Da. Carbamidomethyl was set as a fixed modification, while oxidation of methionine was set as a variable modification. The Minora node was used to determine relative protein abundance between samples using the default settings. Percolator was used as the FDR calculator, filtering out peptides which had a q-value greater than 0.01.

Filtered MS data analysis

Request a detailed protocol

To identify proteins that were significantly different between two groups, the log2 fold change (FC) and the -log10 of the p-value were plotted in a volcano plot and we utilized the most stringent cut-off parameters of log2FC >1 and -log10(p-value)>1.3. Significantly decreased proteins among two groups were inserted in PANTHER classification system (Mi et al., 2021) (http://pantherdb.org/) to classify protein type. To understand what types of biological processes (BPs), molecular functions (MFs), and cellular components (CCs) were shifted on each condition, we inserted all significantly decreased proteins in the gene ontology classification tool DAVID (Huang et al., 2009) (https://david.ncifcrf.gov/). Protein network analysis was performed using the Search Tool for Retrieval of Interacting Genes/Proteins (STRING), v11.0 (Szklarczyk et al., 2019), and ECM-related proteins were further classified using MatrisomeDB (Hynes and Naba, 2012) (https://web.mit.edu/hyneslab/matrisome/).

Single-cell isolation

Request a detailed protocol

A total of 16 FDL tendons per group per age were pooled together into low glucose Dulbecco’s Modified Eagle Medium (DMEM) and subsequently digested in Collagenase Type I (5 mg/ml) (Worthington Biochemical, Lakewood, NJ, LS004196) and Collagenase Type IV (1 mg/ml) (Worthington Biochemical, Lakewood, NJ, LS004188). Young WT tendons were completely digested after two hours, while young DTR and aged C57BL/6 J WT tendons after ninety minutes. After digestion, the single-cell suspension was filtered for any potential debris via a 70 μm and a 50 μm cell strainer and resuspended in Dulbecco’s Phosphate Buffer Solution (dPBS). Next, the single cell suspension was centrifuged for 10 min at 500xg while being at 4 °C. After removal of supernatant, the single cell suspension was resuspended in 0.5% Bovine Serum Albumin (BSA).

Single-cell RNA sequencing and analysis

Request a detailed protocol

Single-cell RNA sequencing (scRNAseq) was performed in collaboration with the UR Genomics Research Center. Libraries were prepared using a Chromium Single Cell 3 Reagent Kit (version 3, 10 X Genomics, Pleasanton, CA) following the directions of the manufacturer. Cells were loaded into the kit and processed using a chromium controller (10 X Genomics). Following library preparation and quality control (QC), libraries were sequenced using the S2 NovaSeq flow cell system (Illumina, San Diego, CA), generating an average of 65,000 reads per cell for all groups. Raw data quality control and downstream analyses were performed with R-4.1.2 and the Seurat package (4.0.6) (Stuart et al., 2019). Cells with <1000 or>5000 genes, as well as cells with >10% mitochondrial genes were removed from the dataset. After filtering out low quality cells, there were 8359 cells for the young (6 M old) WT group, 6554 cells for the young (6 M old) DTR group, and 4798 cells for the 21 M old C57BL/6 J WT group. All three different datasets were integrated to determine alterations of different cell subpopulations between groups using the ‘FindIntegrationAnchors’ function (dims = 1:20). The function ‘IntegrateData’ was applied in the anchor set with the default additional arguments. Next, data was scaled using the ‘ScaleData’ with default parameters and principal component analysis (PCA) was performed on the integrated dataset to compute 20 principal components (PCs). Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction was applied, and the Shared Nearest Neighbor (SSN) graph was constructed by utilizing dimensions 1:20 as input feature. To identify cell clusters, the ‘FindClusters’ function was utilized on the integrated dataset at a resolution of 0.1, resulting in seven distinct cell clusters. To identify genetic markers of each single cluster and annotate the different clusters to known cell types, the top differentially expressed genes of each cluster were identified in the heatmap (Figure 3—figure supplement 1). Next, the ‘FindAllMarkers’ function was used to identify upregulated genes for each cluster. The average gene expression level was calculated across each cluster. The minimum percentage of cells in which the gene is detected in each cluster was set to 50%. The average log2 change threshold was set to at least 0.25. Marker gene lists were then compared to a set of literature-defined gene markers via direct literature search and by utilizing CellMarker software (http://bio-bigdata.hrbmu.edu.cn/CellMarker/search.jsp) (Zhang et al., 2019). Significance was determined using Wilcoxon rank sum test with p values adjusted based on Bonferroni correction applying all features in the data set (p_val_adj <0.05). The tenocytes cluster from the integrated data was subset out from the rest using the ‘Subset’ and were independently re-clustered following the same steps described above.

Cell-cell communication analysis

Request a detailed protocol

Cellular autocrine and paracrine communication was performed using the R CellChat package version 1.4.0 (Jin et al., 2021; Jin et al., 2022). To assess tenocyte-tenocyte communication, tenocyte clusters 1–3 from the integrated data were subsetted and a CellChat object of tenocytes 1–3 was created for each condition using the ‘createCellChat’ function. After proper annotation, the ‘CellChatDB.mouse’ database was utilized for our study To identify overexpressed genes, the ‘identifyOverExpressedGenes’ function was utilized. To identify significant cellular interactions, the ‘identifyOverExpressedInteractions’ function was utilized. Finally, to infer communication probabilities, the ‘computeCommunProb’ function was utilized. Next, to study the effect of depletion and natural aging on tenocyte-tenocyte communication, a merged CellChat object was created for the 6 M WT vs 6 M DTR, and 6 M WT vs 21 M B6 groups, respectively, using the ‘mergeCellChat’ function. To assess tenocyte-macrophage communication, tenocytes and macrophage clusters from the integrated data were subsetted. The same steps mentioned above for the tenocyte-tenocyte communication analysis were also followed for tenocyte-macrophage communication. To identify the differential number of interactions between two conditions, the ‘netVisual_diffInteraction’ function was utilized. To identify specific signaling pathways that were conserved or expressed only in one condition, the ‘rankNet’ function was utilizes. Next, the ‘netAnalysis_signalingRole_heatmap’ function were applied to identify the ‘outgoing’ and ‘incoming’ patterns of signaling pathways for each different cell population and how that compares between 2 conditions. Finally, specific ligand-receptor interactions were identified for specific signaling pathways of interest utilizing the ‘netVisual_bubble’ function.

Statistical analysis

Request a detailed protocol

Sample sizes for cell density, dispersion, and biomechanical properties were determined based on post-hoc power calculations of previously published work (Best et al., 2021; Ackerman et al., 2019). Quantitative data was analyzed via GraphPad Prism and is presented as mean ± standard deviation (SD). Either a student’s t-test or two-way analysis of variance (ANOVA) with Tukey’s test was used as appropriate. Mice were randomly selected for specific experimental outcome metrics prior to the start of an experiment or surgery and quantitative data (e.g. DAPI quantification, SHG dispersion levels, biomechanical properties) were analyzed in a blinded manner. For all experiments, an n=1 represents one mouse. p-values ≤0.05 were considered significant. * Indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001, **** indicates p<0.0001 (Perez-Riverol et al., 2022).

Data availability

Single cell RNA sequencing data has been deposited at Gene Expression Omnibus (GEO) (Accession # GSE214929) and are publicly available as of the date of publication. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (Perez-Riverol et al., 2022) with the dataset identifier PXD037230.

The following previously published data sets were used
    1. Korcari A
    2. Nichols AEC
    3. Buckley MR
    4. Loiselle AE
    (2023) NCBI Gene Expression Omnibus
    ID GSE214929. Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype.
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE214929
    1. Korcari A
    2. Nichols AEC
    3. Buckley MR
    4. Loiselle AE
    (2023) PRIDE
    ID PXD037230. Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype.
    https://www.ebi.ac.uk/pride/archive/projects/PXD037230

References

    1. Korcari A
    2. Nichols AE
    3. O’Neil M
    4. Loiselle AE
    (2021b)
    Ligament and tendon tissue engineering
    Musculoskeletal Tissue Engineering 5:81.
    1. Qabar AN
    2. Lin Z
    3. Wolf FW
    4. O’Shea KS
    5. Lawler J
    6. Dixit VM
    (1994)
    Thrombospondin 3 is a developmentally regulated heparin binding protein
    The Journal of Biological Chemistry 269:1262–1269.

Decision letter

  1. Mei Wan
    Reviewing Editor; Johns Hopkins University, United States
  2. Carlos Isales
    Senior Editor; Augusta University, United States
  3. Nathanial Dyment
    Reviewer; University of Pennsylvania, United States

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype" for consideration by eLife. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Carlos Isales as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Nathanial Dyment (Reviewer #1).

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

This is a generally well-executed set of study, the data from which largely supports the conclusions. The manuscript would be strengthened by (1) improved clarity of the methods and figures as pointed out by the reviewers; (2) including more introduction/discussion on Gbp2; and (3) including more discussion on the limitations of using the DTA mice to model the aging process (eg. artificial, not a perfect model of aging…).

Reviewer #1 (Recommendations for the authors):

This study developed a novel model of accelerated tendon extracellular matrix (ECM) aging via depletion of Scleraxis-lineage (ScxLin) cells in young mice (DTR). The authors found the depletion reduced cell numbers to similar baselines as aged tendons, indicating that a minimum cell number threshold exists to maintain tendon. This cell loss coincided with disrupted ECM organization and reduced mechanical properties. The DTR and aged tendons had similar protein composition with the main difference compared to young healthy tendons being a loss of high turnover ECM proteins. Via sc-seq, DTR and aged tendon had fewer biosynthetic cells, correlating with loss of certain ECM proteins. Interestingly, the remaining cells in the DTR model differed from aged tendons. While somewhat artificial, this depletion model system is an interesting way to investigate mechanisms that lead to reduced ECM turnover and matrix degeneration. I commend the authors for conducting this extensive study and have mostly minor comments to help with data interpretation and presentation.

1. In Figure 3E, the authors show the relative proportions of tenocytes in the 6M WT, 6M DTR, and 21M B6 groups, what about other cell types? It would be great to show pie charts of all of the cell clusters in one of the supplemental figures (maybe Figure S4). Did the other cell populations increased or decrease? I know that the authors plan to publish the epitenon data in a separate paper but it would still help the readers in this paper to understand the relative proportions.

2. In Figure 4F, it appears that there is a subset within the Tenocyte 1 cluster (right 1/3 of the heatmap for Tenocyte 1). Is this a unique subset? Did the authors conduct upregulated biological processes on this subset?

3. The authors used GBP2 as a unique marker for the tenocyte 1 population but didn't discuss it further. What is the function of GBP2 and does it help explain some of the degenerative changes seen in aging tendons?

4. Similar to my previous point, Thbs signaling was demonstrated to be a common pathway in both DTR and aging. What do we know about this signaling axis and its role in tendon? It would be great to touch on Thbs and GBP2 in the discussion.

5. Can the authors please clarify the following sentence in the discussion? Which data in the paper support this statement? "Finally, these data suggest that the initiation and early evidence of degeneration occurs much earlier in life than previously appreciated."

6. Reference 1 and 36 are the same.

7. The fact that the cell density 3M after DTR reached the same minimum threshold as aged tendons and that DTR tendons didn't progressively lose more cells with age is quite interesting, as the authors indicated.

Reviewer #2 (Recommendations for the authors):

In this manuscript, the authors characterize the proteomic and single RNA Seq profiles of tendons that are aged or depleted of Scx+ cells. They show that the tendons depleted of Scx+ cells share a similar cellularity, collagen disorganization, and impaired biomechanics as the aged tendon. They find that ECM proteins/regulators are mis-expressed in Scx depleted and aged tendons, with the aged tendons having a population of tenocytes that expression a program of inflammatory markers.

1) In all figures, font on the heat maps are out of focus and very small – would make it easier for the reader if this was improved.

2) Methods – For the biomechanical testing – it is not clear how was the strain applied to the tendon controlled to be the same for each tendon.

3) Methods – For the DT toxin injections, what time points were the mice injected?

4) Figure 1D- there may be a labeling error of the graph – 3M post DT is not the same as 6M old WT.

5) With the proteomics data, how do you know if the decrease in protein expression of these ECM molecules is due to the decrease in cellularity or each tendon cell has decreased expression of these markers? Would be useful to validate this with expression of a candidate protein marker in WT /DT treated/aged tenocytes.

6) Please define Gbp2 – what is this molecule?

7) In Figure 5 – there is graphic representation of genes enhanced in the different mouse groups, but are there any genes downregulated compared to WT?

8) In the discussion, the authors mention that it would be helpful to prevent apoptosis of tenocytes during aging – where is the evidence or citation that shows cell death is increased in aged tenocytes?

https://doi.org/10.7554/eLife.84194.sa1

Author response

Reviewer #1 (Recommendations for the authors):

This study developed a novel model of accelerated tendon extracellular matrix (ECM) aging via depletion of Scleraxis-lineage (ScxLin) cells in young mice (DTR). The authors found the depletion reduced cell numbers to similar baselines as aged tendons, indicating that a minimum cell number threshold exists to maintain tendon. This cell loss coincided with disrupted ECM organization and reduced mechanical properties. The DTR and aged tendons had similar protein composition with the main difference compared to young healthy tendons being a loss of high turnover ECM proteins. Via sc-seq, DTR and aged tendon had fewer biosynthetic cells, correlating with loss of certain ECM proteins. Interestingly, the remaining cells in the DTR model differed from aged tendons. While somewhat artificial, this depletion model system is an interesting way to investigate mechanisms that lead to reduced ECM turnover and matrix degeneration. I commend the authors for conducting this extensive study and have mostly minor comments to help with data interpretation and presentation.

1. In Figure 3E, the authors show the relative proportions of tenocytes in the 6M WT, 6M DTR, and 21M B6 groups, what about other cell types? It would be great to show pie charts of all of the cell clusters in one of the supplemental figures (maybe Figure S4). Did the other cell populations increased or decrease? I know that the authors plan to publish the epitenon data in a separate paper but it would still help the readers in this paper to understand the relative proportions.

Thank you for your comment, we now include new Figure 3—figure supplement 1D, which has a bar chart depicting the % of each cell cluster across the three conditions (6M WT, 6M DTR, 21M WT). Key take homes from these data include the high proportion of epitenon cells that are captured, including 58% of cells in the 21M WT group. While we speculate this may be due to combination of the low cellularity in the aged tendons, as well as the superficial nature of the epitenon, which may make these cells more amenable to digest. However, further work is needed to validate this speculation. Furthermore, there was a greater proportion of tendon resident macrophages captured in the depleted and aged groups, suggesting these populations may be more resistant to age-related declines.

2. In Figure 4F, it appears that there is a subset within the Tenocyte 1 cluster (right 1/3 of the heatmap for Tenocyte 1). Is this a unique subset? Did the authors conduct upregulated biological processes on this subset?

This is a great point, indeed the right 1/3 of the heatmap for tenocytes 1 in Figure 4F exhibits some DEGs compared to the rest 2/3 of that same cluster, with this segment representing part of the Tenocytes 1 cluster that is only found in aged tendons. As we discuss in Figure 5F-J, these aged cells demonstrate up-regulation of age-related and pro-inflammatory genes such as IL6, Hspa1a, Hspa1b, Mt1, Mt2 and the downregulation of genes related to ECM/collagen biosynthesis and ECM organization such as Col6a3, Col1a1, Sparc, Vcan, Chad, Col1a2, and thus demonstrate shifts in biological processes.

3. The authors used GBP2 as a unique marker for the tenocyte 1 population but didn't discuss it further. What is the function of GBP2 and does it help explain some of the degenerative changes seen in aging tendons?

Thank you for this suggestion. Based on this, we now provide additional text related to GBP2. While GBP2 has not been studied in the context of tendon, or musculoskeletal biology, GBP2 is downstream of IFN-γ signaling and exhibits host defense and anti-microbial functions [Tretina et al., J. Exp Med 2019; Kutsch et al., FEBS J 2021]. Consistent with this, Tenocytes 1, which are defined by specific expression of GBP2, demonstrate biological processes (BPs) related to innate immune and defense response such as response to cytokine, innate immune response, response to IL-1 (Figure 4F, G). We have clarified that expression of GBP2 is an effective marker of Tenocytes 1, but the functional role of GBP2 in tenocytes remains to be determined.

4. Similar to my previous point, Thbs signaling was demonstrated to be a common pathway in both DTR and aging. What do we know about this signaling axis and its role in tendon? It would be great to touch on Thbs and GBP2 in the discussion.

Thank you for this suggestion. We have added additional text to the discussion to address this. Syndecans are one of the main transmembrane proteins that bind with (thrombospondins) TSPs and since there was a decrease of TSPs in both DTR and aging, that resulted in a similar loss of TSP-Syndecan pathway among the two conditions. TSP2 -Syndecan 4 pathway exhibited the highest ligand-receptor communication in terms of statistical significance and communication probability in the young WT, and it was completely lost with both DTR and aging.

While there are no studies focusing on the roles of Syndecans in the tendon field, there is a limited number of studies regarding the roles of Syndecans in musculoskeletal tissues. Cornelison et al., as well as Ronning et al., have shown that Syndecan-4 KO mice exhibit impairments muscle development, homeostasis, and healing after injury [Cornelison et al., Genes Dev 2004; Ronning et al., Front Cell Dev Biol 2020].

The text now states: “Finally, our CellChat analyses identified that Thbs2-Sdcn4 signaling was significantly impaired with both DTR and aging, suggesting that this pathway might be important for maintenance of tendon homeostasis. While this specific pathway has not been extensively studied in tendon, previous work has shown that Sdcn 4 is required for muscle development, homeostasis, and healing after injury 82, 83. As such, future studies can better define the role of this signaling axis in tendon health, as it may represent promising therapeutic target.”

5. Can the authors please clarify the following sentence in the discussion? Which data in the paper support this statement? "Finally, these data suggest that the initiation and early evidence of degeneration occurs much earlier in life than previously appreciated."

This sentence has been clarified. Our intention was to highlight the greater understanding of the timeline of age-related tendon degeneration that our data provide. More specifically, since we show that the decline in cell density occurs at 10-12M of age (approximately middle age), and subsequently initiates a degenerative cascade, including loss of high-turnover rate ECM components, these data provide greater temporal context on the age-related degeneration phenotypes identified in prior studies. For example, many prior studies have identified substantial declines in tendon cell density with advanced aging (e.g., 21-24M), relative to young mice. However, based on these studies it was unknown when precisely the drop in tendon cell density occurred, or even whether this was related to age-related degeneration.

The revised text now states: “Finally, these data provide more granular information on the timeline in which age-associated declines in tendon cell density actually occur and provide a functional and mechanistic link between declines in tendon cell density and initiation of tendon degeneration.”

6. Reference 1 and 36 are the same.

Thanks for pointing this out, we have removed reference 36.

7. The fact that the cell density 3M after DTR reached the same minimum threshold as aged tendons and that DTR tendons didn't progressively lose more cells with age is quite interesting, as the authors indicated.

Thank you for this comment. As the reviewer notes, there seems to be a minimum threshold for cell density, and the mechanisms that regulate this threshold representing an intriguing mechanism that we will pursue in the future. For example, would a higher dose of DT, or additional doses of DT be able to force cell density below this threshold?

Reviewer #2 (Recommendations for the authors):

In this manuscript, the authors characterize the proteomic and single RNA Seq profiles of tendons that are aged or depleted of Scx+ cells. They show that the tendons depleted of Scx+ cells share a similar cellularity, collagen disorganization, and impaired biomechanics as the aged tendon. They find that ECM proteins/regulators are mis-expressed in Scx depleted and aged tendons, with the aged tendons having a population of tenocytes that expression a program of inflammatory markers.

1) In all figures, font on the heat maps are out of focus and very small – would make it easier for the reader if this was improved.

We apologize for this. We have updated these figures with higher resolution and larger font.

2) Methods – For the biomechanical testing – it is not clear how was the strain applied to the tendon controlled to be the same for each tendon.

This is a great point. To clarify, after prepping the tendons for biomechanical testing, we measured the gauge length of each tendon and applied a displacement-controlled stretching of 1% of the initial gauge length per second until failure (1% strain rate). The gauge length was kept consistent between all groups, thus the strain rate applied to all tendons was consistent. Moreover, we have previously validated the experimental measurements of the tendon biomechanical properties using Finite Elements Analysis (Korcari et al., JMBBM, 2022).

3) Methods – For the DT toxin injections, what time points were the mice injected?

Thank you for your comment, as shown in Figure 1A, 3M old mice (both WT and DTR) were injected with DT for 5 consecutive days and then harvested after 3, 6, and 9M post depletion. To increase clarity in the manuscript, we have also included this info in the methods Mice section.

4) Figure 1D- there may be a labeling error of the graph – 3M post DT is not the same as 6M old WT.

Thank you for identifying this issue. To clarify- both WT (Cre-) and DTR (Cre+) mice were injected with DT at 3M of age. The 3M post-DT cohort was thus harvested at 6M of age. In Figure 1D, data from both the 6M old WT (3M post-DT) and the 6M old DTR (3M post-DT) groups are included as comparisons lines. We have added additional information to Figure 1A to make the experimental timeline and relative ages more clear.

5) With the proteomics data, how do you know if the decrease in protein expression of these ECM molecules is due to the decrease in cellularity or each tendon cell has decreased expression of these markers? Would be useful to validate this with expression of a candidate protein marker in WT /DT treated/aged tenocytes.

This is an important point. To address this, we used Chad and Coch as example. These ECM proteins were significantly decreased in aged and DTR tendons in the proteomics analysis (Figure 2M). We then examined these genes in the single cell RNA seq dataset (Figure 2—figure supplement 3). At the transcript level, Tenocytes 1 and Tenocytes 3 are the predominant populations expressing Coch and Chad. While the cells that remained in the 6M DTR and the 21M B6 group demonstrated high levels of Coch and Chad expression (Figure 2—figure supplement 3A and D), there was a substantial decline in the total number and the proportion of CocH+ and Chad+ cells in these groups (Figure 2—figure supplement 3C and F). To further confirm the data in Figure 2—figure supplement 3A and D, we have plotted the mRNA expression levels of Coch, Chad and other ECM components that are down-regulated with DTR and/or aging in Author response image 1. Collectively, these data suggest that it is a decline in the number of cells that express these ECM components rather than down-regulation of expression on a per-cell basis.

Author response image 1
Download asset Open asset

6) Please define Gbp2 – what is this molecule?

Thank you for this suggestion. Based on this, we now provide additional text related to GBP2. While GBP2 has not been studied in the context of tendon, or musculoskeletal biology, GBP2 is downstream of IFN-γ signaling and exhibits host defense and anti-microbial functions [Tretina et al., J. Exp Med 2019; Kutsch et al., FEBS J 2021]. Consistent with this, Tenocytes 1, which are defined by specific expression of GBP2, demonstrate biological processes (BPs) related to innate immune and defense response such as response to cytokine, innate immune response, response to IL-1 (Figure 4F, G). We have clarified that expression of GBP2 is an effective marker of Tenocytes 1, but the functional role of GBP2 in tenocytes remains to be determined.

7) In Figure 5 – there is graphic representation of genes enhanced in the different mouse groups, but are there any genes downregulated compared to WT?

Thank you for this question. As shown in Figure 5 there are many differentially expressed (significantly increased or decreased) genes, across each set of comparisons. Using Figure 5B as an example, we compare differential gene expression in 6M WT Tenocytes 1 vs. 6M DTR Tenocytes 1. Genes in blue are significantly increased in 6M WT Tenocytes 1 vs. 6M DTR Tenocytes 1, that is, these are genes that are downregulated in the 6M DTR Tenocyte 1 cluster. In contrast, genes that are significantly reduced in 6M WT Tenoctyes 1 vs. 6M DTR Tenocytes (increased expression in 6M DTR Tenocyte 1) are shown in red. In addition, the heatmaps in Figure 5C, H, and M show up-regulation (purple) and down-regulation (yellow) of genes in 6M WT, relative to their respective comparison (Figure 5C: 6M DTR Tenocytes 1, Figure 5H: 21M B6 Tenocytes 1, Figure 5M: 6M DTR Tenocytes 2)

8) In the discussion, the authors mention that it would be helpful to prevent apoptosis of tenocytes during aging – where is the evidence or citation that shows cell death is increased in aged tenocytes?

Thank you for pointing this out. While we do have preliminary data supporting an age-dependent degree of apoptosis (increased cleaved caspase 3 at 9-10 months, followed by a decline at 12-13 months), we have not included these data in this manuscript, and have therefore revised this statement. The revised text now states: “As such, we have identified preventing the loss of biosynthetic tenocytes (whether via apoptosis or other mechanisms) as a critical intervention point for maintaining tendon structure-function.”

https://doi.org/10.7554/eLife.84194.sa2

Article and author information

Author details

  1. Antonion Korcari

    1. Center for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, United States
    2. Department of Biomedical Engineering, University of Rochester, Rochester, United States
    Contribution
    Conceptualization, Formal analysis, Investigation, Writing – original draft
    Competing interests
    No competing interests declared

  2. Anne EC Nichols

    Center for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, United States
    Contribution
    Conceptualization, Formal analysis, Methodology, Writing - review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8754-7735

  3. Mark R Buckley

    1. Center for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, United States
    2. Department of Biomedical Engineering, University of Rochester, Rochester, United States
    Contribution
    Resources, Methodology, Writing - review and editing
    Competing interests
    No competing interests declared

  4. Alayna E Loiselle

    1. Center for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, United States
    2. Department of Biomedical Engineering, University of Rochester, Rochester, United States
    Contribution
    Conceptualization, Funding acquisition, Writing - review and editing
    For correspondence
    alayna_loiselle@urmc.rochester.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7548-6653

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR073169)

  • Alayna E Loiselle

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR077527)

  • Alayna E Loiselle

National Institute of Arthritis and Musculoskeletal and Skin Diseases (K99 AR080757)

  • Anne EC Nichols

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported in part by NIH/ NIAMS R01AR073169 and R01AR077527 (to AEL), and K99 AR080757 (to AECN). The Histology, Biochemistry and Molecular Imaging (HBMI) Core was supported by NIH/ NIAMS P30AR069655. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Ethics

This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal studies were approved by the University Committee for Animal Resources (UCAR) (protocol 2014-004E).

Senior Editor

  1. Carlos Isales, Augusta University, United States

Reviewing Editor

  1. Mei Wan, Johns Hopkins University, United States

Reviewer

  1. Nathanial Dyment, University of Pennsylvania, United States

Publication history

  1. Preprint posted: January 21, 2022 (view preprint)
  2. Received: October 13, 2022
  3. Accepted: January 18, 2023
  4. Accepted Manuscript published: January 19, 2023 (version 1)
  5. Version of Record published: February 8, 2023 (version 2)

Copyright

© 2023, Korcari et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 515
    Page views
  • 92
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Antonion Korcari
  2. Anne EC Nichols
  3. Mark R Buckley
  4. Alayna E Loiselle
(2023)
Scleraxis-lineage cells are required for tendon homeostasis and their depletion induces an accelerated extracellular matrix aging phenotype
eLife 12:e84194.
https://doi.org/10.7554/eLife.84194

Categories and tags

Research organism

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine

    Atf3 defines a population of pulmonary endothelial cells essential for lung regeneration

    Terren K Niethamer, Lillian I Levin ... Edward E Morrisey
    Research Article

    Following acute injury, the capillary vascular bed in the lung must be repaired to reestablish gas exchange with the external environment. Little is known about the transcriptional and signaling factors that drive pulmonary endothelial cell (EC) proliferation and subsequent regeneration of pulmonary capillaries, as well as their response to stress. Here, we show that the transcription factor Atf3 is essential for the regenerative response of the mouse pulmonary endothelium after influenza infection. Atf3 expression defines a subpopulation of capillary ECs enriched in genes involved in endothelial development, differentiation, and migration. During lung alveolar regeneration, this EC population expands and increases the expression of genes involved in angiogenesis, blood vessel development, and cellular response to stress. Importantly, endothelial cell-specific loss of Atf3 results in defective alveolar regeneration, in part through increased apoptosis and decreased proliferation in the endothelium. This leads to the general loss of alveolar endothelium and persistent morphological changes to the alveolar niche, including an emphysema-like phenotype with enlarged alveolar airspaces lined with regions that lack vascular investment. Taken together, these data implicate Atf3 as an essential component of the vascular response to acute lung injury that is required for successful lung alveolar regeneration.

    1. Stem Cells and Regenerative Medicine

    Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis

    Rachel Warren, Handeng Lyu ... Stijn P De Langhe
    Research Article Updated

    Idiopathic pulmonary fibrosis (IPF) consists of fibrotic alveolar remodeling and progressive loss of pulmonary function. Genetic and experimental evidence indicates that chronic alveolar injury and failure to properly repair the respiratory epithelium are intrinsic to IPF pathogenesis. Loss of alveolar type 2 (AT2) stem cells or mutations that either impair their self-renewal and/or impair their differentiation into AT1 cells can serve as a trigger of pulmonary fibrosis. Recent reports indicate increased YAP activity in respiratory epithelial cells in IPF lungs. Individual IPF epithelial cells with aberrant YAP activation in bronchiolized regions frequently co-express AT1, AT2, conducting airway selective markers and even mesenchymal or EMT markers, demonstrating ‘indeterminate’ states of differentiation and suggesting that aberrant YAP signaling might promote pulmonary fibrosis. Yet, Yap and Taz have recently also been shown to be important for AT1 cell maintenance and alveolar epithelial regeneration after Streptococcus pneumoniae-induced injury. To investigate how epithelial Yap/Taz might promote pulmonary fibrosis or drive alveolar epithelial regeneration, we inactivated the Hippo pathway in AT2 stem cells resulting in increased nuclear Yap/Taz, and found that this promotes their alveolar regenerative capacity and reduces pulmonary fibrosis following bleomycin injury by pushing them along the AT1 cell lineage. Vice versa, inactivation of both Yap1 and Wwtr1 (encoding Taz) or Wwtr1 alone in AT2 cell stem cells impaired alveolar epithelial regeneration and resulted in increased pulmonary fibrosis upon bleomycin injury. Interestingly, the inactivation of only Yap1 in AT2 stem cells promoted alveolar epithelial regeneration and reduced pulmonary fibrosis. Together, these data suggest that epithelial Yap promotes, and epithelial Taz reduces pulmonary fibrosis suggesting that targeting Yap but not Taz-mediated transcription might help promote AT1 cell regeneration and treat pulmonary fibrosis.

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine

    Single-cell transcriptomic atlas of lung microvascular regeneration after targeted endothelial cell ablation

    Rafael Soares Godoy, Nicholas D Cober ... Duncan J Stewart
    Research Article Updated

    We sought to define the mechanism underlying lung microvascular regeneration in a model of severe acute lung injury (ALI) induced by selective lung endothelial cell ablation. Intratracheal instillation of DT in transgenic mice expressing human diphtheria toxin (DT) receptor targeted to ECs resulted in ablation of >70% of lung ECs, producing severe ALI with near complete resolution by 7 days. Using single-cell RNA sequencing, eight distinct endothelial clusters were resolved, including alveolar aerocytes (aCap) ECs expressing apelin at baseline and general capillary (gCap) ECs expressing the apelin receptor. At 3 days post-injury, a novel gCap EC population emerged characterized by de novo expression of apelin, together with the stem cell marker, protein C receptor. These stem-like cells transitioned at 5 days to proliferative endothelial progenitor-like cells, expressing apelin receptor together with the pro-proliferative transcription factor, Foxm1, and were responsible for the rapid replenishment of all depleted EC populations by 7 days post-injury. Treatment with an apelin receptor antagonist prevented ALI resolution and resulted in excessive mortality, consistent with a central role for apelin signaling in EC regeneration and microvascular repair. The lung has a remarkable capacity for microvasculature EC regeneration which is orchestrated by newly emergent apelin-expressing gCap endothelial stem-like cells that give rise to highly proliferative, apelin receptor-positive endothelial progenitors responsible for the regeneration of the lung microvasculature.